Structure activity relationship and therapeutic uses of dopaminergic ergots.
Markstein
R
R
Preclinical Research, Sandoz Pharma Ltd, Basel, Switzerland.
Seiler
M P
MP
Jaton
A
A
Briner
U
U
D000818:Animals; D015259:Dopamine Agents / Q000737:chemistry* / Q000627:therapeutic use*; D004873:Ergolines / Q000737:chemistry / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000737:chemistry* / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000737:chemistry / Q000627:therapeutic use; D010617:Phenanthridines / Q000737:chemistry / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D015259:Dopamine Agents; D004873:Ergolines; D004876:Ergot Alkaloids; D007211:Indoles; D010617:Phenanthridines; C054531:CY 208-243